XML 152 R114.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Segment and Geographic Information - Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Apr. 28, 2023
Apr. 26, 2024
Apr. 28, 2023
Apr. 29, 2022
Segment Reporting Information [Line Items]        
Reportable segment operating profit   $ 5,144 $ 5,485 $ 5,752
Other non-operating income, net   412 515 318
Amortization of intangible assets   (1,693) (1,698) (1,733)
Stock-based compensation   (393) (355) (359)
Restructuring and associated costs $ (300) (389) (647) (335)
Certain litigation charges, net   (149) 30 (95)
Income before income taxes   4,837 5,364 5,517
Reportable segments        
Segment Reporting Information [Line Items]        
Reportable segment operating profit   11,979 11,664 12,740
Reportable segments | Cardiovascular        
Segment Reporting Information [Line Items]        
Reportable segment operating profit   4,474 4,522 4,596
Reportable segments | Neuroscience        
Segment Reporting Information [Line Items]        
Reportable segment operating profit   3,940 3,712 3,858
Reportable segments | Medical Surgical        
Segment Reporting Information [Line Items]        
Reportable segment operating profit   3,170 3,048 3,698
Reportable segments | Diabetes        
Segment Reporting Information [Line Items]        
Reportable segment operating profit   394 383 588
Reportable segments | Other operating segment        
Segment Reporting Information [Line Items]        
Reportable segment operating profit   10 (89) (31)
Segment reconciling items        
Segment Reporting Information [Line Items]        
Corporate   (1,784) (1,763) (1,724)
Interest expense   (719) (636) (553)
Other non-operating income, net   412 515 318
Amortization of intangible assets   (1,693) (1,698) (1,733)
Stock-based compensation   (393) (355) (358)
Centralized distribution costs   (1,609) (1,558) (1,741)
Currency   68 465 70
Restructuring and associated costs   (389) (647) (335)
Acquisition and divestiture-related items   (777) (345) (838)
Certain litigation charges, net   (149) 30 (95)
IPR&D charges   0 0 (101)
Medical device regulations   (119) (150) (102)
Commitments to the Medtronic Foundation and Medtronic LABS   $ 0 $ (70) $ 0